from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0369c/-

LFCtreatmentdescriptionclass of inhibitor

0.118

Amikacinug/mL Amikacintranslation

0.589

Cap5-10ug/mL Capreomycintranslation

1.153

Rox10-50 ug/mL Roxithromycintranslation

-0.210

SM2-5 ug/mL Streptomycintranslation

0.443

Tet5-10 ug/mL Tetracyclinetranslation

0.072

Rif0.2-5ug/mL Rifampicintranscription

0.381

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.410

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.040

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.240

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.013

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.354

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.656

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.216

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.841

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.792

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.687

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.426

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.804

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.481

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.646

KCN5-20 ug/mL Potassium cyaniderespiration

1.023

NaN30.2-2 mM Sodium aziderespiration

-1.542

Nigericin50 uM Nigericinrespiration

-0.246

TRC10-150 ug/mL Triclosanrespiration

1.080

TRZ10-25 ug/mL Thioridazinerespiration

0.593

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.221

menadione6-10 ug/mL Menadionerespiration

0.211

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.022

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.942

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.495

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.203

NRP_1Non-replicating persistence stage 1dosRassociated

-0.263

Amp0.2mg/mL AmpicillincellWall

0.103

Cephalexin20-100 ug/mL CephalexincellWall

-0.044

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.470

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.148

EMB10-20 ug/mL EthambutolcellWall

0.455

Eta12-40 ug/mL EthionamidecellWall

0.815

INH0.2-0.4 ug/mL IsoniazidcellWall

0.672

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.024

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.188

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.418

BZA0.12 mg/mL BenzamidearomaticAmides

-0.733

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.175

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.092

H2O24 mM hydrogen peroxideDNAdamaging

-0.225

Levo10 ug/mL LevofloxacinDNAdamaging

-0.303

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.354

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.374

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.356

UVUV-irradiationDNAdamaging

-0.001

ARP41-4 ug/mL Antitubercular compound ARP4?

0.453

Antimycin12.5-50 ug/mL Antimycin A?

-0.511

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.736

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.227

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.155

PA8240.2-2 ug/mL PA-824?

0.664

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.445

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.373

Verapamil50 uM Verapamil?

-0.943

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.209

methoxatin10-20 ug/mL Methoxatin?